

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.46935282 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.46935282 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.04068120 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 6.00952840 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.65211967 |
| 6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.50308304 |
| 7 | response to peptidoglycan (GO:0032494) | 5.17623069 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 4.73010782 |
| 9 | mast cell activation (GO:0045576) | 4.64653071 |
| 10 | defense response to protozoan (GO:0042832) | 4.49476618 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 4.47919759 |
| 12 | platelet dense granule organization (GO:0060155) | 4.44611046 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42097476 |
| 14 | mast cell degranulation (GO:0043303) | 4.35147167 |
| 15 | mast cell activation involved in immune response (GO:0002279) | 4.35147167 |
| 16 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.33017841 |
| 17 | viral transcription (GO:0019083) | 4.28956078 |
| 18 | negative regulation of B cell apoptotic process (GO:0002903) | 4.25392679 |
| 19 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.25137208 |
| 20 | angiogenesis involved in wound healing (GO:0060055) | 4.19423933 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.17951983 |
| 22 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.15716935 |
| 23 | response to protozoan (GO:0001562) | 4.12068261 |
| 24 | translational termination (GO:0006415) | 4.03751071 |
| 25 | Peyers patch development (GO:0048541) | 4.01474795 |
| 26 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.01474795 |
| 27 | regulation of B cell apoptotic process (GO:0002902) | 3.95020157 |
| 28 | positive regulation of granulocyte differentiation (GO:0030854) | 3.94633923 |
| 29 | mature B cell differentiation involved in immune response (GO:0002313) | 3.89272042 |
| 30 | cellular response to interferon-beta (GO:0035458) | 3.83940410 |
| 31 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.80515656 |
| 32 | response to interferon-beta (GO:0035456) | 3.77191342 |
| 33 | necroptotic process (GO:0070266) | 3.75605100 |
| 34 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.73748782 |
| 35 | megakaryocyte development (GO:0035855) | 3.68471597 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.68462638 |
| 37 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.64295132 |
| 38 | DNA deamination (GO:0045006) | 3.63415183 |
| 39 | negative regulation of granulocyte differentiation (GO:0030853) | 3.61041062 |
| 40 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.59583964 |
| 41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.59547829 |
| 42 | positive thymic T cell selection (GO:0045059) | 3.58681578 |
| 43 | negative regulation of interleukin-17 production (GO:0032700) | 3.57784942 |
| 44 | translational elongation (GO:0006414) | 3.57726676 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57577144 |
| 46 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56242232 |
| 47 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.56200141 |
| 48 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.55387023 |
| 49 | mature B cell differentiation (GO:0002335) | 3.54350205 |
| 50 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54269538 |
| 51 | positive regulation of response to tumor cell (GO:0002836) | 3.52555851 |
| 52 | positive regulation of immune response to tumor cell (GO:0002839) | 3.52555851 |
| 53 | regulation of immune response to tumor cell (GO:0002837) | 3.52555851 |
| 54 | regulation of response to tumor cell (GO:0002834) | 3.52555851 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.50893884 |
| 56 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.46676405 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.46676405 |
| 58 | cotranslational protein targeting to membrane (GO:0006613) | 3.46509555 |
| 59 | maturation of SSU-rRNA (GO:0030490) | 3.45666238 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.43148399 |
| 61 | protein targeting to ER (GO:0045047) | 3.42082349 |
| 62 | T cell homeostasis (GO:0043029) | 3.39114443 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.37485602 |
| 64 | negative regulation of type 2 immune response (GO:0002829) | 3.37271999 |
| 65 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.37006522 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36510634 |
| 67 | definitive hemopoiesis (GO:0060216) | 3.36097253 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.34296578 |
| 69 | positive regulation of mast cell degranulation (GO:0043306) | 3.34296578 |
| 70 | * regulation of B cell differentiation (GO:0045577) | 3.33909955 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30743681 |
| 72 | cell differentiation involved in metanephros development (GO:0072202) | 3.29061927 |
| 73 | * lymphoid progenitor cell differentiation (GO:0002320) | 3.28218147 |
| 74 | leukocyte degranulation (GO:0043299) | 3.26475294 |
| 75 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.24999869 |
| 76 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.24832517 |
| 77 | regulation of mast cell degranulation (GO:0043304) | 3.23783951 |
| 78 | ribosomal small subunit biogenesis (GO:0042274) | 3.23686836 |
| 79 | protein localization to endoplasmic reticulum (GO:0070972) | 3.22304696 |
| 80 | cellular extravasation (GO:0045123) | 3.20894135 |
| 81 | regulation of necroptotic process (GO:0060544) | 3.19372690 |
| 82 | response to hydroperoxide (GO:0033194) | 3.17469805 |
| 83 | positive regulation of natural killer cell activation (GO:0032816) | 3.16816307 |
| 84 | regulation of granulocyte differentiation (GO:0030852) | 3.16393172 |
| 85 | regulation of hypersensitivity (GO:0002883) | 3.15073003 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 3.14956089 |
| 87 | regulation of gamma-delta T cell activation (GO:0046643) | 3.14577213 |
| 88 | deoxyribonucleotide catabolic process (GO:0009264) | 3.14324550 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 3.12975758 |
| 90 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.12843089 |
| 91 | response to UV-B (GO:0010224) | 3.12657379 |
| 92 | viral life cycle (GO:0019058) | 3.11755875 |
| 93 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.10613066 |
| 94 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.09571671 |
| 95 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.08350811 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 3.08012416 |
| 97 | regulation of RIG-I signaling pathway (GO:0039535) | 3.07975971 |
| 98 | telomere maintenance via recombination (GO:0000722) | 3.07332981 |
| 99 | B cell mediated immunity (GO:0019724) | 3.06928304 |
| 100 | DNA strand elongation (GO:0022616) | 3.06775579 |
| 101 | programmed necrotic cell death (GO:0097300) | 3.06264254 |
| 102 | deoxyribose phosphate catabolic process (GO:0046386) | 3.05566636 |
| 103 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.04200229 |
| 104 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.04047949 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03584210 |
| 106 | regulation of mast cell activation (GO:0033003) | 3.03325407 |
| 107 | regulation of germinal center formation (GO:0002634) | 3.03062882 |
| 108 | secretory granule organization (GO:0033363) | 3.02278583 |
| 109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00888021 |
| 110 | T cell migration (GO:0072678) | 3.00495052 |
| 111 | cellular protein complex disassembly (GO:0043624) | 2.99376772 |
| 112 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99249978 |
| 113 | germinal center formation (GO:0002467) | 2.99178565 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98503737 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.96364111 |
| 116 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.95368023 |
| 117 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.95128435 |
| 118 | regulation of natural killer cell activation (GO:0032814) | 2.93768785 |
| 119 | regulation of female gonad development (GO:2000194) | 2.93344647 |
| 120 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.91927878 |
| 121 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.91145435 |
| 122 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.89738346 |
| 123 | type I interferon signaling pathway (GO:0060337) | 2.89013335 |
| 124 | cellular response to type I interferon (GO:0071357) | 2.89013335 |
| 125 | pinocytosis (GO:0006907) | 2.88215750 |
| 126 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87424730 |
| 127 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87205060 |
| 128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.86706507 |
| 129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.86706507 |
| 130 | modulation by symbiont of host immune response (GO:0052553) | 2.86706507 |
| 131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.86706507 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.86706507 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.86706507 |
| 134 | histamine secretion (GO:0001821) | 2.86088440 |
| 135 | response to type I interferon (GO:0034340) | 2.85903311 |
| 136 | regulation of regulated secretory pathway (GO:1903305) | 2.85584451 |
| 137 | cellular response to exogenous dsRNA (GO:0071360) | 2.84931410 |
| 138 | regulation of antigen processing and presentation (GO:0002577) | 2.83191258 |
| 139 | endothelium development (GO:0003158) | 2.82942533 |
| 140 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81745039 |
| 141 | negative regulation of necroptotic process (GO:0060546) | 2.81490563 |
| 142 | lymphocyte homeostasis (GO:0002260) | 2.81435884 |
| 143 | negative regulation of phagocytosis (GO:0050765) | 2.80259094 |
| 144 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.79667401 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.79397171 |
| 146 | positive regulation of B cell activation (GO:0050871) | 2.77047042 |
| 147 | myeloid dendritic cell differentiation (GO:0043011) | 2.76977092 |
| 148 | negative thymic T cell selection (GO:0045060) | 2.76785053 |
| 149 | necrotic cell death (GO:0070265) | 2.74981097 |
| 150 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.74601152 |
| 151 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.74601152 |
| 152 | regulation of growth of symbiont in host (GO:0044126) | 2.74601152 |
| 153 | negative regulation of growth of symbiont in host (GO:0044130) | 2.74601152 |
| 154 | protein complex disassembly (GO:0043241) | 2.73639618 |
| 155 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73628862 |
| 156 | polyketide metabolic process (GO:0030638) | 2.73376873 |
| 157 | doxorubicin metabolic process (GO:0044598) | 2.73376873 |
| 158 | daunorubicin metabolic process (GO:0044597) | 2.73376873 |
| 159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73353112 |
| 160 | mitotic recombination (GO:0006312) | 2.72448012 |
| 161 | * leukocyte homeostasis (GO:0001776) | 2.71928899 |
| 162 | cell wall macromolecule catabolic process (GO:0016998) | 2.71677471 |
| 163 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71620456 |
| 164 | microglial cell activation (GO:0001774) | 2.71228736 |
| 165 | neutrophil activation (GO:0042119) | 2.71218106 |
| 166 | regulation of interleukin-17 production (GO:0032660) | 2.71109968 |
| 167 | dosage compensation (GO:0007549) | 2.70978724 |
| 168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.68089194 |
| 169 | regulation of necrotic cell death (GO:0010939) | 2.67197465 |
| 170 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64375301 |
| 171 | telomere maintenance via telomere lengthening (GO:0010833) | 2.64197045 |
| 172 | regulation of histone phosphorylation (GO:0033127) | 2.63733626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.22020694 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56644724 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.99975511 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68419332 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45155938 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.39064519 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.23684761 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.20467527 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.15123447 |
| 10 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.75431454 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68080323 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67340121 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64520756 |
| 14 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59485346 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.57394380 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.49743649 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48529015 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46763820 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.46044669 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43429188 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40378410 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37055685 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19366194 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18893947 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.15899822 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.15160291 |
| 27 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.12069015 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10659834 |
| 29 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10320995 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05716914 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05540818 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 2.04810363 |
| 33 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.04711485 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03456049 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.01768601 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96018923 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95482450 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94151692 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.93552413 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89743477 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88681698 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88667605 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88095495 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.86826474 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83405852 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.83080192 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78286758 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.76633177 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.76589775 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75981631 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69068484 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67962734 |
| 53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66520022 |
| 54 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.65683855 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65486609 |
| 56 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60330241 |
| 57 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57846748 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57813394 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57029176 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56136409 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54541570 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54129433 |
| 63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.53939235 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52276221 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48589428 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47429418 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46955122 |
| 68 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42544685 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.39513211 |
| 70 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38854294 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38200219 |
| 72 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37830139 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36031593 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35558519 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32614349 |
| 76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29599788 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29100614 |
| 78 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29046195 |
| 79 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26565695 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26321305 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23979096 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.22402702 |
| 83 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20973436 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19981540 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19920252 |
| 86 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.19048682 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17331687 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13940041 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13582380 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13292854 |
| 91 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11924331 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11811828 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.10468979 |
| 94 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06133988 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05583236 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04554333 |
| 97 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02889570 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01862727 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00924558 |
| 100 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00726792 |
| 101 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00490303 |
| 102 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00338853 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00303905 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00165583 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99543079 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99540363 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99068133 |
| 108 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98827822 |
| 109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98304795 |
| 110 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98255944 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97749673 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95282374 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94324704 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93367713 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92987723 |
| 116 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.91958588 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 0.91851618 |
| 118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.91479805 |
| 119 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90794963 |
| 120 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.89411237 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88924290 |
| 122 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86379236 |
| 123 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85719383 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85634220 |
| 125 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.85618627 |
| 126 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83226969 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82832097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.22681769 |
| 2 | MP0000685_abnormal_immune_system | 3.90637410 |
| 3 | * MP0002396_abnormal_hematopoietic_system | 3.90178169 |
| 4 | MP0005174_abnormal_tail_pigmentation | 3.51996328 |
| 5 | MP0005671_abnormal_response_to | 2.84600874 |
| 6 | MP0001800_abnormal_humoral_immune | 2.84071726 |
| 7 | * MP0009785_altered_susceptibility_to | 2.75149125 |
| 8 | MP0004808_abnormal_hematopoietic_stem | 2.61614161 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.57834565 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.57600361 |
| 11 | * MP0002398_abnormal_bone_marrow | 2.54585671 |
| 12 | * MP0005025_abnormal_response_to | 2.54364386 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.52960566 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.52437806 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.51892533 |
| 16 | * MP0002723_abnormal_immune_serum | 2.50985292 |
| 17 | * MP0001819_abnormal_immune_cell | 2.49221474 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.42765863 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.42765863 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.39366256 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.37731696 |
| 22 | MP0001873_stomach_inflammation | 2.35451819 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.33627294 |
| 24 | MP0003436_decreased_susceptibility_to | 2.32477309 |
| 25 | MP0001790_abnormal_immune_system | 2.31459524 |
| 26 | MP0005387_immune_system_phenotype | 2.31459524 |
| 27 | MP0000716_abnormal_immune_system | 2.24422138 |
| 28 | MP0002095_abnormal_skin_pigmentation | 2.16194777 |
| 29 | * MP0002419_abnormal_innate_immunity | 2.15256360 |
| 30 | * MP0000689_abnormal_spleen_morphology | 2.08370224 |
| 31 | MP0002006_tumorigenesis | 2.03435537 |
| 32 | MP0003183_abnormal_peptide_metabolism | 2.00230714 |
| 33 | MP0003303_peritoneal_inflammation | 2.00115362 |
| 34 | * MP0002429_abnormal_blood_cell | 1.99214695 |
| 35 | MP0002722_abnormal_immune_system | 1.96890274 |
| 36 | MP0004147_increased_porphyrin_level | 1.90947306 |
| 37 | MP0001853_heart_inflammation | 1.88183620 |
| 38 | MP0010094_abnormal_chromosome_stability | 1.83643508 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.79813185 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.76011821 |
| 41 | MP0000490_abnormal_crypts_of | 1.75802825 |
| 42 | MP0002405_respiratory_system_inflammati | 1.72880602 |
| 43 | MP0008057_abnormal_DNA_replication | 1.62527628 |
| 44 | MP0003866_abnormal_defecation | 1.62390979 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.59032129 |
| 46 | * MP0000703_abnormal_thymus_morphology | 1.54178173 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.43483771 |
| 48 | MP0002132_abnormal_respiratory_system | 1.43240334 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.39147230 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.39053720 |
| 51 | MP0002254_reproductive_system_inflammat | 1.38624961 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.37028790 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.35511960 |
| 54 | MP0008058_abnormal_DNA_repair | 1.34653042 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.33066129 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.32492068 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.31201541 |
| 58 | MP0003077_abnormal_cell_cycle | 1.31052648 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.27679714 |
| 60 | MP0009278_abnormal_bone_marrow | 1.26786076 |
| 61 | * MP0008469_abnormal_protein_level | 1.23004786 |
| 62 | MP0000371_diluted_coat_color | 1.16777518 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.16236346 |
| 64 | MP0002933_joint_inflammation | 1.16115004 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.15250802 |
| 66 | * MP0008007_abnormal_cellular_replicative | 1.12318025 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.11084710 |
| 68 | MP0004947_skin_inflammation | 1.10971497 |
| 69 | MP0000681_abnormal_thyroid_gland | 1.05972414 |
| 70 | MP0001188_hyperpigmentation | 1.04755008 |
| 71 | MP0004510_myositis | 1.02648379 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.00291458 |
| 73 | MP0003943_abnormal_hepatobiliary_system | 0.99656455 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.95532768 |
| 75 | MP0009379_abnormal_foot_pigmentation | 0.95499739 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.91568485 |
| 77 | MP0000313_abnormal_cell_death | 0.90936949 |
| 78 | MP0003252_abnormal_bile_duct | 0.90268419 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 0.90152408 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.89560090 |
| 81 | MP0002009_preneoplasia | 0.88414761 |
| 82 | MP0005310_abnormal_salivary_gland | 0.88341167 |
| 83 | MP0003075_altered_response_to | 0.88204562 |
| 84 | MP0003787_abnormal_imprinting | 0.87465803 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.85473297 |
| 86 | MP0009764_decreased_sensitivity_to | 0.85431234 |
| 87 | MP0003111_abnormal_nucleus_morphology | 0.84744058 |
| 88 | MP0002075_abnormal_coat/hair_pigmentati | 0.83642526 |
| 89 | MP0000343_altered_response_to | 0.83208103 |
| 90 | MP0006082_CNS_inflammation | 0.81746147 |
| 91 | MP0003724_increased_susceptibility_to | 0.77093258 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.76923052 |
| 93 | MP0002822_catalepsy | 0.76740877 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.74530600 |
| 95 | MP0005409_darkened_coat_color | 0.74281035 |
| 96 | MP0001663_abnormal_digestive_system | 0.74244706 |
| 97 | MP0009697_abnormal_copulation | 0.73670822 |
| 98 | MP0001851_eye_inflammation | 0.72414918 |
| 99 | MP0000598_abnormal_liver_morphology | 0.71727356 |
| 100 | MP0009763_increased_sensitivity_to | 0.71503350 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.68943597 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.65866096 |
| 103 | MP0008877_abnormal_DNA_methylation | 0.65418374 |
| 104 | MP0005535_abnormal_body_temperature | 0.65055689 |
| 105 | MP0000350_abnormal_cell_proliferation | 0.64381443 |
| 106 | MP0003828_pulmonary_edema | 0.63819912 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.63584386 |
| 108 | MP0000604_amyloidosis | 0.63265192 |
| 109 | MP0000858_altered_metastatic_potential | 0.61793764 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.61503086 |
| 111 | MP0003786_premature_aging | 0.60510705 |
| 112 | MP0005166_decreased_susceptibility_to | 0.60509893 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.60355291 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.58857145 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.58744447 |
| 116 | MP0004142_abnormal_muscle_tone | 0.58371466 |
| 117 | MP0001533_abnormal_skeleton_physiology | 0.57243229 |
| 118 | MP0008873_increased_physiological_sensi | 0.55541526 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.54375309 |
| 120 | MP0008995_early_reproductive_senescence | 0.53227296 |
| 121 | MP0010307_abnormal_tumor_latency | 0.53167301 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.52845874 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.52563449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.84273691 |
| 2 | Thrombocytosis (HP:0001894) | 5.35884187 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.32900648 |
| 4 | Myositis (HP:0100614) | 5.06526801 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.40898327 |
| 6 | IgM deficiency (HP:0002850) | 4.38252307 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.32623896 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.14015668 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.05971174 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.97428194 |
| 11 | * Acute lymphatic leukemia (HP:0006721) | 3.90749711 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.89518426 |
| 13 | Granulocytopenia (HP:0001913) | 3.80992694 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.76186143 |
| 15 | Aplastic anemia (HP:0001915) | 3.69086534 |
| 16 | Reticulocytopenia (HP:0001896) | 3.66471028 |
| 17 | Recurrent viral infections (HP:0004429) | 3.51537958 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.49264792 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.45991037 |
| 20 | Stomatitis (HP:0010280) | 3.44225702 |
| 21 | B lymphocytopenia (HP:0010976) | 3.34011658 |
| 22 | Abnormality of B cell number (HP:0010975) | 3.34011658 |
| 23 | Colitis (HP:0002583) | 3.33816876 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.30737959 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.29831922 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.28862729 |
| 27 | Obstructive lung disease (HP:0006536) | 3.28862729 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.23231148 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.21186115 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 3.19131241 |
| 31 | Nasal polyposis (HP:0100582) | 3.17919357 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 3.17016377 |
| 33 | Meningitis (HP:0001287) | 3.14877281 |
| 34 | Recurrent skin infections (HP:0001581) | 3.09434160 |
| 35 | Combined immunodeficiency (HP:0005387) | 3.03832597 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 2.99129512 |
| 37 | Hypothermia (HP:0002045) | 2.97530180 |
| 38 | Gastrointestinal stroma tumor (HP:0100723) | 2.94737833 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.90115523 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.86476227 |
| 41 | Cellulitis (HP:0100658) | 2.82175334 |
| 42 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.81624617 |
| 43 | Poikiloderma (HP:0001029) | 2.81279056 |
| 44 | Reduced antithrombin III activity (HP:0001976) | 2.77400251 |
| 45 | Eosinophilia (HP:0001880) | 2.75708013 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.73206118 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.73206118 |
| 48 | Type II lissencephaly (HP:0007260) | 2.70804562 |
| 49 | Chronic sinusitis (HP:0011109) | 2.68790034 |
| 50 | Fatigue (HP:0012378) | 2.67346764 |
| 51 | Abnormality of T cells (HP:0002843) | 2.66746756 |
| 52 | Prostate neoplasm (HP:0100787) | 2.66410413 |
| 53 | Spondylolisthesis (HP:0003302) | 2.66053102 |
| 54 | Viral hepatitis (HP:0006562) | 2.65462449 |
| 55 | Abnormality of macrophages (HP:0004311) | 2.65274013 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.59607160 |
| 57 | Abnormality of DNA repair (HP:0003254) | 2.59292779 |
| 58 | Chest pain (HP:0100749) | 2.59144296 |
| 59 | Leukocytosis (HP:0001974) | 2.57675656 |
| 60 | IgG deficiency (HP:0004315) | 2.51426379 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.50717420 |
| 62 | Thoracic kyphosis (HP:0002942) | 2.48902881 |
| 63 | Urticaria (HP:0001025) | 2.48101173 |
| 64 | Lymphopenia (HP:0001888) | 2.46547216 |
| 65 | Thyroiditis (HP:0100646) | 2.44964733 |
| 66 | Encephalitis (HP:0002383) | 2.41653165 |
| 67 | Hypoplasia of the thymus (HP:0000778) | 2.41624540 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.39752945 |
| 69 | Recurrent sinusitis (HP:0011108) | 2.38311579 |
| 70 | Metaphyseal dysplasia (HP:0100255) | 2.38067179 |
| 71 | Lymphoma (HP:0002665) | 2.37031028 |
| 72 | Skin rash (HP:0000988) | 2.34139867 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.34114315 |
| 74 | Severe visual impairment (HP:0001141) | 2.32932082 |
| 75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32702299 |
| 76 | * Acute myeloid leukemia (HP:0004808) | 2.31297762 |
| 77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.30929945 |
| 78 | Chronic diarrhea (HP:0002028) | 2.29574015 |
| 79 | Abnormality of male internal genitalia (HP:0000022) | 2.28658744 |
| 80 | Hypoproteinemia (HP:0003075) | 2.28445349 |
| 81 | Amaurosis fugax (HP:0100576) | 2.27479234 |
| 82 | Myelodysplasia (HP:0002863) | 2.25369013 |
| 83 | Pallor (HP:0000980) | 2.25274417 |
| 84 | Petechiae (HP:0000967) | 2.24987535 |
| 85 | Gingival bleeding (HP:0000225) | 2.21427277 |
| 86 | Vasculitis (HP:0002633) | 2.20983148 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.20926099 |
| 88 | Failure to thrive in infancy (HP:0001531) | 2.20653573 |
| 89 | Abnormality of the columella (HP:0009929) | 2.20621303 |
| 90 | Erythema (HP:0010783) | 2.20260128 |
| 91 | Sepsis (HP:0100806) | 2.19852400 |
| 92 | Amyloidosis (HP:0011034) | 2.18343744 |
| 93 | Bronchitis (HP:0012387) | 2.17966668 |
| 94 | Arterial thrombosis (HP:0004420) | 2.15560762 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.15398894 |
| 96 | Agnosia (HP:0010524) | 2.13463347 |
| 97 | Syringomyelia (HP:0003396) | 2.12723251 |
| 98 | Spinal cord lesions (HP:0100561) | 2.12723251 |
| 99 | Orchitis (HP:0100796) | 2.12361063 |
| 100 | Abnormality of the thymus (HP:0000777) | 2.11915125 |
| 101 | Entropion (HP:0000621) | 2.10297323 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08583383 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08583383 |
| 104 | Abnormal protein glycosylation (HP:0012346) | 2.08583383 |
| 105 | Abnormal glycosylation (HP:0012345) | 2.08583383 |
| 106 | Albinism (HP:0001022) | 2.08224840 |
| 107 | Increased IgE level (HP:0003212) | 2.08201768 |
| 108 | Hemoptysis (HP:0002105) | 2.07343254 |
| 109 | Epistaxis (HP:0000421) | 2.07296168 |
| 110 | Osteomyelitis (HP:0002754) | 2.07252852 |
| 111 | Retrobulbar optic neuritis (HP:0100654) | 2.04523358 |
| 112 | Optic neuritis (HP:0100653) | 2.04523358 |
| 113 | Pulmonary infiltrates (HP:0002113) | 2.03756619 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 2.03182434 |
| 115 | Neutropenia (HP:0001875) | 1.98575869 |
| 116 | Self-mutilation (HP:0000742) | 1.98553235 |
| 117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97899550 |
| 118 | Emphysema (HP:0002097) | 1.97417427 |
| 119 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97295213 |
| 120 | Chromsome breakage (HP:0040012) | 1.96584076 |
| 121 | Birth length less than 3rd percentile (HP:0003561) | 1.96464836 |
| 122 | Stomach cancer (HP:0012126) | 1.96263386 |
| 123 | Verrucae (HP:0200043) | 1.92567860 |
| 124 | Papilloma (HP:0012740) | 1.92567860 |
| 125 | Abnormal platelet function (HP:0011869) | 1.91058853 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.91058853 |
| 127 | Abnormality of the fingertips (HP:0001211) | 1.90744988 |
| 128 | Increased cerebral lipofuscin (HP:0011813) | 1.90069492 |
| 129 | Alveolar cell carcinoma (HP:0006519) | 1.89873918 |
| 130 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89222953 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.89089892 |
| 132 | Leukopenia (HP:0001882) | 1.88935786 |
| 133 | Broad face (HP:0000283) | 1.87785525 |
| 134 | Exertional dyspnea (HP:0002875) | 1.87551695 |
| 135 | Cerebellar dysplasia (HP:0007033) | 1.86796652 |
| 136 | Macrocytic anemia (HP:0001972) | 1.86538874 |
| 137 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85542769 |
| 138 | Clubbing of toes (HP:0100760) | 1.84676740 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.84648501 |
| 140 | 11 pairs of ribs (HP:0000878) | 1.82649546 |
| 141 | Pulmonary embolism (HP:0002204) | 1.82384521 |
| 142 | Skin ulcer (HP:0200042) | 1.81578038 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.79736522 |
| 144 | Abnormality of the pleura (HP:0002103) | 1.79514418 |
| 145 | Thrombophlebitis (HP:0004418) | 1.78943310 |
| 146 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.78940683 |
| 147 | Thickened calvaria (HP:0002684) | 1.78865941 |
| 148 | Increased IgM level (HP:0003496) | 1.78100394 |
| 149 | Hypochromic anemia (HP:0001931) | 1.77279138 |
| 150 | Decreased central vision (HP:0007663) | 1.73725065 |
| 151 | Constricted visual fields (HP:0001133) | 1.71153616 |
| 152 | Cutis marmorata (HP:0000965) | 1.70441974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.95264053 |
| 2 | * KIT | 3.52212107 |
| 3 | TNIK | 3.21361049 |
| 4 | BRSK2 | 2.96262716 |
| 5 | IRAK4 | 2.84926138 |
| 6 | TEC | 2.84260469 |
| 7 | BMPR2 | 2.62110463 |
| 8 | ADRBK2 | 2.59019260 |
| 9 | PIK3CG | 2.39065610 |
| 10 | BTK | 2.35640993 |
| 11 | WEE1 | 2.30197370 |
| 12 | NME2 | 2.16168416 |
| 13 | ACVR1B | 2.16000281 |
| 14 | TBK1 | 2.14980884 |
| 15 | TGFBR1 | 2.10241231 |
| 16 | MAP3K14 | 1.92212322 |
| 17 | SYK | 1.88535063 |
| 18 | PRPF4B | 1.82067769 |
| 19 | TYK2 | 1.81579335 |
| 20 | JAK3 | 1.78046343 |
| 21 | CCNB1 | 1.77364363 |
| 22 | TNK2 | 1.76024312 |
| 23 | EEF2K | 1.75859540 |
| 24 | IKBKB | 1.67717370 |
| 25 | CDK19 | 1.66401996 |
| 26 | TXK | 1.66201679 |
| 27 | ZAP70 | 1.61794865 |
| 28 | * CSF1R | 1.60627951 |
| 29 | STK16 | 1.53438594 |
| 30 | IKBKE | 1.51099287 |
| 31 | MATK | 1.45166048 |
| 32 | FES | 1.44514468 |
| 33 | MAP2K3 | 1.43826296 |
| 34 | SCYL2 | 1.43419532 |
| 35 | BLK | 1.40127235 |
| 36 | ERN1 | 1.38660044 |
| 37 | RIPK4 | 1.37463934 |
| 38 | NLK | 1.30950324 |
| 39 | TAOK3 | 1.29790624 |
| 40 | CDK6 | 1.28184975 |
| 41 | VRK1 | 1.27838954 |
| 42 | BRSK1 | 1.26332711 |
| 43 | TRPM7 | 1.24911594 |
| 44 | MAP3K13 | 1.23666073 |
| 45 | PIM2 | 1.23607452 |
| 46 | NUAK1 | 1.21785649 |
| 47 | MAPKAPK3 | 1.18758040 |
| 48 | CAMKK2 | 1.14070913 |
| 49 | MAP3K12 | 1.13404110 |
| 50 | CDK12 | 1.13002203 |
| 51 | CLK1 | 1.12541231 |
| 52 | LYN | 1.09322306 |
| 53 | VRK2 | 1.08244637 |
| 54 | CDK8 | 1.00760657 |
| 55 | * LCK | 0.98225156 |
| 56 | DYRK3 | 0.97016641 |
| 57 | SIK3 | 0.94569505 |
| 58 | RPS6KB2 | 0.91587479 |
| 59 | MUSK | 0.89921054 |
| 60 | JAK2 | 0.86350041 |
| 61 | BMPR1B | 0.84981828 |
| 62 | CHUK | 0.82663708 |
| 63 | PRKCQ | 0.80971037 |
| 64 | PASK | 0.79075145 |
| 65 | RPS6KC1 | 0.78018420 |
| 66 | RPS6KL1 | 0.78018420 |
| 67 | PIM1 | 0.77164208 |
| 68 | MAP3K10 | 0.76562342 |
| 69 | BCKDK | 0.75010090 |
| 70 | MAP3K1 | 0.74732742 |
| 71 | GRK6 | 0.74587975 |
| 72 | ITK | 0.74079402 |
| 73 | TESK2 | 0.74042101 |
| 74 | BRD4 | 0.73957744 |
| 75 | LRRK2 | 0.73721747 |
| 76 | RIPK1 | 0.71671824 |
| 77 | BUB1 | 0.70996887 |
| 78 | MAP2K2 | 0.68912182 |
| 79 | ATR | 0.68721399 |
| 80 | HCK | 0.68517442 |
| 81 | TSSK6 | 0.66187686 |
| 82 | MAP4K2 | 0.64568653 |
| 83 | MKNK1 | 0.64065289 |
| 84 | MAP2K6 | 0.63971886 |
| 85 | MAPK12 | 0.63649808 |
| 86 | MAPKAPK5 | 0.62730564 |
| 87 | TAOK2 | 0.62465683 |
| 88 | PRKAA2 | 0.60091609 |
| 89 | CDC7 | 0.57458077 |
| 90 | MAP3K6 | 0.57199603 |
| 91 | MAPK4 | 0.57009362 |
| 92 | HIPK2 | 0.56409223 |
| 93 | PIK3CA | 0.56194408 |
| 94 | CAMK1 | 0.54489519 |
| 95 | DAPK1 | 0.53347720 |
| 96 | CDK9 | 0.51541754 |
| 97 | PDK1 | 0.51282032 |
| 98 | TLK1 | 0.50658572 |
| 99 | MAPK7 | 0.50234184 |
| 100 | FRK | 0.49329124 |
| 101 | GRK7 | 0.47004285 |
| 102 | ABL1 | 0.45969368 |
| 103 | YES1 | 0.45299442 |
| 104 | NEK2 | 0.45229791 |
| 105 | PRKD2 | 0.45172169 |
| 106 | CDK7 | 0.44991090 |
| 107 | STK4 | 0.44374625 |
| 108 | RPS6KA4 | 0.43194483 |
| 109 | JAK1 | 0.41741147 |
| 110 | DYRK1B | 0.41127440 |
| 111 | EIF2AK3 | 0.39363431 |
| 112 | MAP3K5 | 0.39207688 |
| 113 | RPS6KA6 | 0.38921554 |
| 114 | CDK4 | 0.38854597 |
| 115 | CDK3 | 0.37508028 |
| 116 | TAF1 | 0.37388259 |
| 117 | MAPK11 | 0.36771259 |
| 118 | CAMKK1 | 0.36509539 |
| 119 | MAPK15 | 0.36237834 |
| 120 | CDK2 | 0.35838786 |
| 121 | KDR | 0.35213190 |
| 122 | SIK2 | 0.34820274 |
| 123 | PRKG2 | 0.34669047 |
| 124 | IRAK3 | 0.34459233 |
| 125 | RPS6KA1 | 0.34329143 |
| 126 | MAPKAPK2 | 0.33513752 |
| 127 | PRKCH | 0.32789020 |
| 128 | PINK1 | 0.32612246 |
| 129 | MAP3K7 | 0.32195989 |
| 130 | AKT2 | 0.32148085 |
| 131 | PAK2 | 0.31758706 |
| 132 | MAP3K11 | 0.30770295 |
| 133 | MKNK2 | 0.30142627 |
| 134 | MARK3 | 0.30070669 |
| 135 | MAPK3 | 0.29690694 |
| 136 | STK10 | 0.27976293 |
| 137 | MAP2K7 | 0.27594793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.68499440 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.23367295 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.54139098 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.27922290 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.27379425 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.26871392 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.04811939 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.75521215 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.56643311 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.49882296 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.39424973 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.35257395 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29251793 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27993566 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27798746 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09818098 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 2.02427093 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.98173187 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92969121 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.89247298 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86942276 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.86769650 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.79052347 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74597754 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66657189 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60861801 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.59657294 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54693808 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54553796 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.53264274 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53042065 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.51334456 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49233496 |
| 34 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41425697 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31454273 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.31084527 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.30952897 |
| 38 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29670582 |
| 39 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22960344 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22460204 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.21077006 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15306865 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12539308 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.12353407 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12348175 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.12091116 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.09471632 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06596163 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05829607 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04036386 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01064528 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.98854184 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.96128246 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91799194 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90425617 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.88352585 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.87164578 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86413320 |
| 59 | Purine metabolism_Homo sapiens_hsa00230 | 0.84946748 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.82565098 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79858322 |
| 62 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77611803 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76967881 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76865390 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.75885437 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75826136 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72618944 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.72384055 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71375753 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70654208 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69006134 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67449130 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66653276 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66614486 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63645415 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63121547 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61947215 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61285523 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59318912 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58200933 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57864258 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54999361 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54886283 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.54239635 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.52904152 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51702261 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51435821 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48467372 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46510408 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45885283 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45238088 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.45138255 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44921016 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44856553 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44457584 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43821385 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43545855 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43315701 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.43311142 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.42681080 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42325148 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41075092 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40445830 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39929895 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.38873338 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37282389 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36855703 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35745680 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34799480 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34782771 |
| 111 | RNA transport_Homo sapiens_hsa03013 | 0.34779747 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34370381 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.33748912 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32188721 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31177941 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29874206 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28030357 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27171189 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26761141 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26337044 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26220911 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25949146 |
| 123 | Renin secretion_Homo sapiens_hsa04924 | 0.24947820 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24770178 |
| 125 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24288268 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24074629 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24022026 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21583612 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21100879 |

